Single and Multiple Oral Doses of Dabigatran Etexilate in Healthy Chinese Subjects
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The objective of the current study is to investigate safety, tolerability and,
pharmacokinetics of dabigatran etexilate following oral administration of single and multiple
oral doses (110mg, 150 mg b.i.d., 7 days) in healthy Chinese subjects.